Seizert Capital Partners, LLC Amgen Inc Transaction History

Seizert Capital Partners, LLC

$2.16 Billion
Q3 2024

A detailed history of Seizert Capital Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 192,842 shares of AMGN stock, worth $50.8 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

192,842

Previous 191,439 0.73%

Holding current value

$50.8 Million

Previous $59.8 Million 3.88%

% of portfolio

2.88%

Previous 3.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $434,060 - $473,344	1,403 Added 0.73%	192,842 $62.1 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $4.19 Million - $5.09 Million	-15,935 Reduced 7.68%	191,439 $59.8 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $698,255 - $842,882	2,597 Added 1.27%	207,374 $59 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $1.72 Million - $1.94 Million	-6,729 Reduced 3.18%	204,777 $59 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $638,020 - $792,120	2,918 Added 1.4%	211,506 $56.8 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $1.03 Million - $1.22 Million	4,810 Added 2.36%	208,588 $46.3 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $3.22 Million - $3.92 Million	14,249 Added 7.52%	203,778 $49.3 Million
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $4.41 Million - $5.61 Million	-19,263 Reduced 9.23%	189,529 $49.8 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $108,638 - $122,524	484 Added 0.23%	208,792 $47.1 Million
Q2 2022 Aug 04, 2022	BUY	$230.71 - $256.74 $1.06 Million - $1.18 Million	4,605 Added 2.26%	208,308 $50.7 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $76,305 - $84,414	348 Added 0.17%	203,703 $49.3 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $636,614 - $728,547	3,201 Added 1.6%	203,355 $45.7 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $981,961 - $1.15 Million	4,626 Added 2.37%	200,154 $42.6 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $8.46 Million - $9.38 Million	36,202 Added 22.72%	195,528 $47.7 Million
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $4.36 Million - $5.08 Million	19,633 Added 14.05%	159,326 $39.6 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $620,794 - $739,255	2,869 Added 2.1%	139,693 $32.1 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $1.96 Million - $2.18 Million	-8,336 Reduced 5.74%	136,824 $34.8 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $1.46 Million - $1.8 Million	-7,396 Reduced 4.85%	145,160 $34.2 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $10.2 Million - $13.5 Million	-55,887 Reduced 26.81%	152,556 $30.9 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1.85 Million - $2.37 Million	-9,755 Reduced 4.47%	208,443 $50.2 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $4.8 Million - $5.75 Million	-27,544 Reduced 11.21%	218,198 $42.2 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $3.32 Million - $3.9 Million	-19,935 Reduced 7.5%	245,742 $45.3 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $102,915 - $116,007	-569 Reduced 0.21%	265,677 $50.5 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $2.03 Million - $2.37 Million	-11,386 Reduced 4.1%	266,246 $51.8 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $5.65 Million - $6.36 Million	30,466 Added 12.33%	277,632 $57.6 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $609,270 - $712,008	3,596 Added 1.48%	247,166 $42.1 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $254,197 - $284,016	1,506 Added 0.62%	243,570 $42.4 Million
Q3 2017 Oct 31, 2017	SELL	$167.29 - $191.0 $2.77 Million - $3.16 Million	-16,538 Reduced 6.4%	242,064 $45.1 Million
Q2 2017 Aug 09, 2017	BUY	N/A	258,602	258,602 $44.5 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Account

Seizert Capital Partners, LLC Amgen Inc Transaction History